Literature DB >> 7831231

[Echography of thyroid nodules. The echography specialist facing the clinician's requirements].

L Leenhardt1, J Tramalloni, H Aurengo, T Delbot, C Guillausseau, A Aurengo.   

Abstract

The risk of malignancy in cases of unique non-functional thyroid nodules ranges from 5 to 20% and since definitive diagnosis can only be provided by the pathology examination, surgical removal could be planned in all cases. The clinician however also has the objective of proposing surgery to as few patients with benign nodules as possible and thus calls upon the echographist to help distinguish between malignant and benign nodules. Thus orders for echography carry an intrinsic request for diagnostic arguments, a precise analysis of the characteristics of the nodule and a description of possible multinodular dystrophy as well as an estimation of the probability of malignancy. The echographist's report must include a precise description of each thyroid lobe, the localization of the nodule, its size, contour, echostructure, echogenicity and calcifications. The cervical lymph node chains must also be explored. An analysis of the surrounding parenchyma can frequently confirm multinodular dystrophy. The size of the nodule is the determining factor in predicting malignancy. While for very small nodules, less than 1 cm in diameter, the malignant nature cannot be reasonably predicted, and inversely for very large nodules, invading an entire lobe, it is usually evident, for intermediate sized nodules, echography is a strategic diagnostic tool. No sign is pathognomonic but an association of arguments can favour malignancy: an unique isolated nodule, irregular contours, lymph node enlargement greater than 1 cm. Hypoechogenicity is another important characteristic with a positive predictive value of 50% to 63%. Overall, the sensitivity of echography is good at 75% with specificity of 61 to 83%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7831231

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  7 in total

1.  Evaluation of diagnostic efficacy of ultrasound scoring system to select thyroid nodules requiring fine needle aspiration biopsy.

Authors:  Afshin Mohammadi; Tohid Hajizadeh
Journal:  Int J Clin Exp Med       Date:  2013-09-01

2.  Characterization of papillary thyroid microcarcinomas using sonographic features in malignant papillary thyroid cancer: a retrospective analysis.

Authors:  Wei-Jun Gu; Hui-Xian Yan; Yu-Kun Luo; Fu-Lin Wang; Guo-Qing Yang; Qing-Hua Guo; Nian Jin; Li Zang; Kang Chen; Jin Du; Xian-Ling Wang; Li-Juan Yang; Jian-Ming Ba; Jing-Tao Dou; Yi-Ming Mu; Chang-Yu Pan; Zhao-Hui Lv
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 3.  Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy.

Authors:  Frederico F R Maia; Denise Engelbrecht Zantut-Wittmann
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

4.  [Analysis of predictors of malignancy of nodular goiters: about 500 cases].

Authors:  Brahim Bouaity; Youssef Darouassi; Mehdi Chihani; Mohamed Mliha Touati; Haddou Ammar
Journal:  Pan Afr Med J       Date:  2016-03-15

5.  Can Ultrasound Predict Malignancy in Patient with Thyroid Cold Nodule?

Authors:  Joko Wiyanto; Achmad Hussein Sundawa Kartamihardja; Trias Nugrahadi
Journal:  World J Nucl Med       Date:  2016-09

6.  MEAN PLATELET VOLUME: AN OVERLOOKED HERALD OF MALIGNANT THYROID NODULES.

Authors:  Mustafa Sit; Gulali Aktas; Bahri Ozer; Mehmet Zahid Kocak; Edip Erkus; Hayri Erkol; Semih Yaman; Haluk Savli
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

7.  A novel computerised quantification of thyroid vascularity in the differentiation of malignant and benign thyroid nodules.

Authors:  Seyed Babak Moosavi Toomatari; Afshin Mohammadi; Nariman Sepehrvand; Seyed Ehsan Moosavi Toomatari; Mohammad Ghasemi-Rad; Saber Zafar Shamspour; Seyfollah Rezayi; Mohammadreza Toubaei; Zahra Karimi Sarabi
Journal:  Pol J Radiol       Date:  2019-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.